For: | Muehler A, Slizgi JR, Kohlhof H, Groeppel M, Peelen E, Vitt D. Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases. World J Gastrointest Pathophysiol 2020; 11(6): 114-130 [PMID: 33362939 DOI: 10.4291/wjgp.v11.i6.114] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v11/i6/114.htm |
Number | Citing Articles |
1 |
Jonathan W. Wallace, David A. Constant, Timothy J. Nice. Interferon Lambda in the Pathogenesis of Inflammatory Bowel Diseases. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.767505
|
2 |
Michele Linsalata, Francesco Russo, Giuseppe Riezzo, Benedetta D’Attoma, Laura Prospero, Antonella Orlando, Antonia Ignazzi, Martina Di Chito, Annamaria Sila, Sara De Nucci, Roberta Rinaldi, Gianluigi Giannelli, Giovanni De Pergola. The Effects of a Very-Low-Calorie Ketogenic Diet on the Intestinal Barrier Integrity and Function in Patients with Obesity: A Pilot Study. Nutrients 2023; 15(11): 2561 doi: 10.3390/nu15112561
|
3 |
Maria-José Cano-Cebrián, David Dahlgren, Fredrik Kullenberg, Karsten Peters, Tobias Olander, Markus Sjöblom, Hans Lennernäs. Chemotherapeutics Combined with Luminal Irritants: Effects on Small-Intestinal Mannitol Permeability and Villus Length in Rats. International Journal of Molecular Sciences 2022; 23(3): 1021 doi: 10.3390/ijms23031021
|
4 |
Natalia Stepanova. How Advanced Is Our Understanding of the Role of Intestinal Barrier Dysfunction in the Pathogenesis of Recurrent Urinary Tract Infections. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.780122
|
5 |
Franziska Buriánek, Christian Gege, Petar Marinković. New developments in celiac disease treatments. Drug Discovery Today 2024; 29(9): 104113 doi: 10.1016/j.drudis.2024.104113
|
6 |
Albert E. Jergens, Shadi Parvinroo, Jamie Kopper, Michael J. Wannemuehler. Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.669913
|
7 |
Maria del Rocio Encarnacion-Garcia, Porfirio Nava. Tight Junctions. 2022; : 109 doi: 10.1007/978-3-030-97204-2_6
|
8 |
Chunhua Yang, Kripa Sharma, Rabeya Jafrin Mow, Eunice Bolay, Anand Srinivasan, Didier Merlin. Unleashing the Potential of Oral Deliverable Nanomedicine in the Treatment of Inflammatory Bowel Disease. Cellular and Molecular Gastroenterology and Hepatology 2024; 18(2): 101333 doi: 10.1016/j.jcmgh.2024.03.005
|
9 |
Chao-Tao Tang, Zi-de Liu, Peng Wang, Chun-Yan Zeng, You-Xiang Chen. Lipopolysaccharide-regulated RNF31/NRF2 axis in colonic epithelial cells mediates homeostasis of the intestinal barrier in ulcerative colitis. Cellular Signalling 2024; 124: 111480 doi: 10.1016/j.cellsig.2024.111480
|
10 |
Qijun Chen, Lixue Wang, Jinlong Chen, Hui Song, Wen Xing, Ziqian Wang, Xueying Song, Hua Yang, Wenhua Zhao. Analysis of Intestinal Metabolites in SR−B1 Knockout Mice via Ultra−Performance Liquid Chromatography Quadrupole Time−of−Flight Mass Spectrometry. Molecules 2023; 28(2): 610 doi: 10.3390/molecules28020610
|
11 |
Chunhai Li, Lixin Wang, Daqian Sun, Tianxiao Yao, Xiuying Xian, Yufeng Cheng. Colitis induced by PD-1 inhibitor combined with platinum-containing dual drug chemotherapy in Lewis mice and its mechanism. Journal of Cancer Research and Therapeutics 2023; 19(4): 939 doi: 10.4103/jcrt.jcrt_2078_22
|
12 |
Yunyun Zou, Aziz Ghaderpour, Bolormaa Munkhbileg, Sang-Uk Seo, Seung-Yong Seong. Taurodeoxycholate ameliorates DSS-induced colitis in mice. International Immunopharmacology 2023; 122: 110628 doi: 10.1016/j.intimp.2023.110628
|
13 |
Zetian Wang, Wei Luo, Qing Wang, Chunzheng Liu, Yanshan Gong, Baitian Li, Xuejiao Zeng, Jiaqi Lin, Zehua Su, Xin Li, Yongze Yu, Zhongmin Liu, Ling Gao, Lijun Liao. hUCMSCs Regulate Bile Acid Metabolism to Prevent Heart Failure–Induced Intestinal Injury by Inhibiting the Activation of the STAT3/NF‐κB/MAPK Signaling Pathway via TGR5. Food Frontiers 2024; doi: 10.1002/fft2.516
|